Skip to content
10-K

Annual Report

DOLBY LABORATORIES, INC. DLB

0001628280-24-048519

← back to feed
Filed
Nov 19, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Stock Repurchased FY 2024 · Sep 27, 2024 $20M
Stock Repurchased FY 2024 · Jun 28, 2024 $35M
Stock Repurchased FY 2024 · Mar 29, 2024 $25M
Stock Repurchased FY 2024 · Dec 29, 2023 $80M
Stock Repurchased FY 2024 · Sep 30, 2022 $530.49M
Short Term Investments FY 2024 · Sep 29, 2023 $139.15M
Cash And Equivalents FY 2024 · Sep 29, 2023 $745.36M
Stockholders Equity FY 2024 · Sep 29, 2023 $2.36B
Current Liabilities FY 2024 · Sep 29, 2023 $422.23M
Total Liabilities FY 2024 · Sep 29, 2023 $607.58M
Current Assets FY 2024 · Sep 29, 2023 $1.49B
Total Assets FY 2024 · Sep 29, 2023 $2.98B
Shares Diluted FY 2024 · Sep 30, 2022 101.98M sh
Dividends Paid FY 2024 · Sep 30, 2022 $100.07M
Capex FY 2024 · Sep 30, 2022 $47.93M
Operating Cash Flow FY 2024 · Sep 30, 2022 $318.58M
Eps Diluted FY 2024 · Sep 30, 2022 $1.81
Eps Basic FY 2024 · Sep 30, 2022 $1.84
Sga Expense FY 2024 · Sep 30, 2022 $275.32M
Rd Expense FY 2024 · Sep 30, 2022 $261.17M
Net Income FY 2024 · Sep 30, 2022 $184.09M
Operating Income FY 2024 · Sep 30, 2022 $206.61M
Gross Profit FY 2024 · Sep 30, 2022 $1.11B
Cost Of Revenue FY 2024 · Sep 30, 2022 $141.36M
Revenue FY 2024 · Sep 30, 2022 $1.25B